Key findings from the 2021 audit report, written for patients, family members and carers

In our 13th Annual Report, we focus on the care received by patients diagnosed with oesophago-gastric cancer between April 2018 and March 2020 in England and Wales, and the outcomes of treatment. We also evaluate the care pathway followed by patients diagnosed with oesophageal high grade dysplasia in England.

A composite indicator that summarises the performance of OG cancer specialist centres in England and Wales, across a range of performance indicators published in the NOGCA 2021 Annual Report.

Use of evidence-based radiotherapy regimens among oesophago-gastric cancer patients with a palliative treatment plan

Key findings from the 2020 audit report, written for patients, family members and carers

A composite indicator that summarises the performance of OG cancer specialist centres in England and Wales, across a range of performance indicators published in the NOGCA 2020 Annual Report.

In our 12th Annual Report, we focus on the care received by patients diagnosed with oesophago-gastric cancer between April 2017 and March 2019 in England and Wales, and the outcomes of treatment. We also evaluate the care pathway followed by patients diagnosed with oesophageal high grade dysplasia in England.

Key findings from the 2019 audit report, written for patients, family members and carers

Comparison of patients captured by NOGCA and the National Cancer Registration and Analysis Service

Why do patients with a curative treatment plan for oesophago-gastric cancer not go on to receive surgery?